VEGFA and endophthalmitis: Endophthalmitis occurred more frequently after dexamethasone implant injections (0.125%, 15/11,954; 1.25 per 1,000 injections) than after anti-VEGF injections (0.033%, 106/318,618; 0.33 per 1,000 injections).